68 Chapter 3 14. Costas L, Frias-Gomez J, Guardiola M, Benavente Y, Pineda M, Pavon MA, et al. New perspectives on screening and early detection of endometrial cancer. Int J Cancer. 2019;145(12):3194-206. • Critical review on why endometrial cancer is suitable for screening and which knowledge gaps hamper implementation of novel technologies for minimally invasive endometrial cancer detection. 15. Syngal S, Brand RE, Church JM, Giardiello FM, Hampel HL, Burt RW, et al. ACG clinical guideline: Genetic testing and management of hereditary gastrointestinal cancer syndromes. Am J Gastroenterol. 2015;110(2):223-62; quiz 63. 16. Chang CC, Wang HC, Liao YP, Chen YC, Weng YC, Yu MH, et al. The feasibility of detecting endometrial and ovarian cancer using DNA methylation biomarkers in cervical scrapings. J Gynecol Oncol. 2018;29(1):e17. •• Training and validation of DNA methylation markers discovered in cervical cancer tissue in cervical scrapes from endometrial and ovarian cancer patients. 17. Fiegl H, Gattringer C, Widschwendter A, Schneitter A, Ramoni A, Sarlay D, et al. Methylated DNA collected by tampons--a new tool to detect endometrial cancer. Cancer Epidemiol Biomarkers Prev. 2004;13(5):882-8. 18. Kulis M, Esteller M. DNA methylation and cancer. Adv Genet. 2010;70:27-56. 19. Leygo C, Williams M, Jin HC, Chan MWY, Chu WK, Grusch M, et al. DNA Methylation as a Noninvasive Epigenetic Biomarker for the Detection of Cancer. Dis Markers. 2017;2017:3726595. 20. Qureshi SA, Bashir MU, Yaqinuddin A. Utility of DNA methylation markers for diagnosing cancer. Int J Surg. 2010;8(3):194-8. 21. Boland PM, Yurgelun MB, Boland CR. Recent progress in Lynch syndrome and other familial colorectal cancer syndromes. CA Cancer J Clin. 2018;68(3):217-31. 22. Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gotzsche PC, Ioannidis JP, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Med. 2009;6(7):e1000100. 23. Moher D, Liberati A, Tetzlaff J, Altman DG, Group P. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. J Clin Epidemiol. 2009;62(10):1006-12. 24. Huang RL, Su PH, Liao YP, Wu TI, Hsu YT, Lin WY, et al. Integrated Epigenomics Analysis Reveals a DNA Methylation Panel for Endometrial Cancer Detection Using Cervical Scrapings. Clin Cancer Res. 2017;23(1):263-72. •• Discovery of DNA methylation makers in two methylomic databases of endometrioid-type endometrial cancer. Discovered methylated genes were validated in cervical scrapes resulting in a marker panel for endometrial cancer detection. 25. Bakkum-Gamez JN, Wentzensen N, Maurer MJ, Hawthorne KM, Voss JS, Kroneman TN, et al. Detection of endometrial cancer via molecular analysis of DNA collected with vaginal tampons. Gynecol Oncol. 2015;137(1):14-22. •• Reporting feasibility of endometrial cancer detection in minimally invasive samples by validation of DNA methylation markers in endometrial brushes and vaginal tampons.
RkJQdWJsaXNoZXIy MjY0ODMw